Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Vial

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Therapie|March 16, 2025
Vaccines and the risk of Guillain-Barré syndrome: A French pharmacovigilance analysisMarie Gligorov, Bénédicte Lebrun-Vignes, Kamel Masmoudi, et al.
Clinics and Research in Hepatology and Gastroenterology|April 26, 2017
Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance surveyJérôme Dumortier, Judith Cottin, Caroline Lavie, et al.
American Journal of Medical Genetics. Part A|February 10, 2012
Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information ServicesMaria Hoeltzenbein, Elisabeth Elefant, Thierry Vial, et al.
Critical Reviews in Oncology/Hematology|February 2, 2015
Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trialsFlorence Ranchon, Thierry Vial, Catherine Rioufol, et al.
Therapie|November 5, 2017
Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational studyZayneb Alami, Marie Sara Agier, Samir Ahid, et al.
International Wound Journal|May 17, 2018
Nicorandil-induced ulcerations: a 10-year observational study of all cases spontaneously reported to the French pharmacovigilance networkValérie Babic, Nadine Petitpain, Claire Guy, et al.
Implementation Science : IS|June 21, 2013
Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trialMaud Keriel-Gascou, Karine Buchet-Poyau, Antoine Duclos, et al.
Therapie|July 6, 2024
[Balancing drug regulation and health democracy: The role of patient and healthcare professional advisors at the ANSM]Patrick Maison, Trystan Bacon, Pascale Daynes, et al.
Fundamental & Clinical Pharmacology|November 21, 2015
Safety profile of etifoxine: A French pharmacovigilance surveyJudith Cottin, Aurore Gouraud, Marie-Josèphe Jean-Pastor, et al.
European Journal of Public Health|March 28, 2026
Age and sex disparities in drug shortage impacts: a 10-year nationwide study in FranceLaëtitia Belgodère, Christopher Leleu, Trystan Bacon, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Therapie|March 16, 2025
Vaccines and the risk of Guillain-Barré syndrome: A French pharmacovigilance analysisMarie Gligorov, Bénédicte Lebrun-Vignes, Kamel Masmoudi, et al.
Clinics and Research in Hepatology and Gastroenterology|April 26, 2017
Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance surveyJérôme Dumortier, Judith Cottin, Caroline Lavie, et al.
American Journal of Medical Genetics. Part A|February 10, 2012
Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information ServicesMaria Hoeltzenbein, Elisabeth Elefant, Thierry Vial, et al.
Critical Reviews in Oncology/Hematology|February 2, 2015
Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trialsFlorence Ranchon, Thierry Vial, Catherine Rioufol, et al.
Therapie|November 5, 2017
Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational studyZayneb Alami, Marie Sara Agier, Samir Ahid, et al.
International Wound Journal|May 17, 2018
Nicorandil-induced ulcerations: a 10-year observational study of all cases spontaneously reported to the French pharmacovigilance networkValérie Babic, Nadine Petitpain, Claire Guy, et al.
Implementation Science : IS|June 21, 2013
Evaluation of an interactive program for preventing adverse drug events in primary care: study protocol of the InPAct cluster randomised stepped wedge trialMaud Keriel-Gascou, Karine Buchet-Poyau, Antoine Duclos, et al.
Therapie|July 6, 2024
[Balancing drug regulation and health democracy: The role of patient and healthcare professional advisors at the ANSM]Patrick Maison, Trystan Bacon, Pascale Daynes, et al.
Fundamental & Clinical Pharmacology|November 21, 2015
Safety profile of etifoxine: A French pharmacovigilance surveyJudith Cottin, Aurore Gouraud, Marie-Josèphe Jean-Pastor, et al.
European Journal of Public Health|March 28, 2026
Age and sex disparities in drug shortage impacts: a 10-year nationwide study in FranceLaëtitia Belgodère, Christopher Leleu, Trystan Bacon, et al.
Pageof 7